The present invention concerns novel taxane derivatives, their use as antitumor agents, and pharmaceutical formulations. The invention claims compounds of formula (I) and the use of compounds of formula (I) or pharmaceutical salts thereof as oral drugs for the treatment of human or veterinary disease, in which: R is phenyl, isopropyl, or tert butyl; R1 is -C(O)RZ in which RZ is (CH¿3?)3CO-, (CH3)3CCH2-, CH3(CH2)3O-, cyclobutyl-, cyclohexyloxy, or (2-furyl); R?2¿ is CH¿3?C(O)O-.
本发明涉及新的
紫杉烷衍
生物,它们作为抗肿瘤剂和制药配方的用途。该发明要求式(I)化合物及其盐作为口服药物用于人类或兽医疾病的治疗,其中:R为苯基,异丙基或叔丁基;R1为-C(O)RZ,其中RZ为(
CH3)3CO-,( )3C -, (
CH2)3O-,
环丁基,环己氧基或(2-
呋喃基);R2为 C(O)O-。